{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:33Z","timestamp":1792788633624,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2019 Roderick D. MacDonald Research Award\/Baylor St. Luke\u2019s Medical Center","award":["19RDM001"],"award-info":[{"award-number":["19RDM001"]}]},{"name":"2021 Roderick D. MacDonald Research Award\/Baylor St. Luke\u2019s Medical Center","award":["21RDM001"],"award-info":[{"award-number":["21RDM001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Four-week dawn-to-dusk dry fasting (DDDF) was previously shown to have a potent anti-inflammatory effect and induce an anti-tumorigenic proteome in the serum and peripheral blood mononuclear cells in subjects without cancer. The study goal was to determine if serum obtained from these subjects without cancer who underwent 4-week DDDF has an anti-tumorigenic effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HepG2 cells were treated with serum collected from four individuals with metabolic syndrome and metabolic dysfunction-associated steatotic liver disease (MASLD) and four healthy individuals who performed 4-week DDDF. The objective was to assess cell proliferation\/viability in HepG2 cells treated with non-fasted and dry-fasted serum and determine proteomic changes in human serum. We comparatively performed 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay and untargeted proteomic analysis using nano ultra-high performance liquid chromatography coupled with tandem mass spectrometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serum collected from 3 out of 4 subjects with metabolic syndrome and MASLD at the end of 4-week DDDF (dry-fasted serum\/V2) significantly reduced proliferation\/viability in HepG2 cells compared with the serum collected before 4-week DDDF (non-fasted serum\/V1). A similar reduction effect on cell proliferation was not observed when HepG2 cells were treated with dry-fasted serum collected from healthy subjects. In addition to the in vitro changes observed, the following circulating gene protein products (GP) demonstrated significant increases or decreases in subjects with metabolic syndrome and MASLD after a 4-week DDDF regimen, compared with their GP levels before the 4-week DDDF: CD248 molecule (mean log2 fold\u2009=\u20098.124, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), dipeptidyl peptidase 4 (mean log2 fold\u2009=\u20090.937, <jats:italic>P<\/jats:italic>\u2009=\u20090.027), lymphatic vessel endothelial hyaluronan receptor 1 (mean log2 fold\u2009=\u20091.054, <jats:italic>P<\/jats:italic>\u2009=\u20090.029), LDL receptor related protein 1 (mean log2 fold\u2009=\u20091.401, <jats:italic>P<\/jats:italic>\u2009=\u20090.031), and beta-2-microglobulin (mean log2 fold= -0.977, <jats:italic>P<\/jats:italic>\u2009=\u20090.033) at the end of 4-week DDDF compared with the GP levels before 4-week DDDF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study demonstrated that dry-fasted serum collected from subjects with metabolic syndrome and MASLD decreased HepG2 cell proliferation in vitro and showed that proteomic changes occurred in vivo. These findings suggest that DDDF may be an effective intervention for inducing proteomic responses that could assist in the prevention and adjunct treatment of cancers associated with metabolic syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12014-025-09547-3","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:21:20Z","timestamp":1750731680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decreased proliferation of HepG2 liver cancer cells in vitro and exhibited proteomic changes in vivo in subjects with metabolic syndrome and metabolic dysfunction-associated steatotic liver disease who performed four-week dawn-to-dusk dry fasting"],"prefix":"10.1186","volume":"22","author":[{"given":"Ayse L.","family":"Mindikoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Eckel-Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antone R.","family":"Opekun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Alzubaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe R.","family":"Crochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasun K.","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"9547_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.","journal-title":"Curr Hypertens Rep"},{"key":"9547_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347.","journal-title":"Hepatology"},{"key":"9547_CR3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr., Spertus JA, Costa F, American Heart A, National Heart L, Blood I. Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood Institute scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"9547_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.RES.0000229685.37402.80","volume":"99","author":"A Picchi","year":"2006","unstructured":"Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res. 2006;99:69\u201377.","journal-title":"Circ Res"},{"key":"9547_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jvs.2011.01.003","volume":"54","author":"D Vykoukal","year":"2011","unstructured":"Vykoukal D, Davies MG. Vascular biology of metabolic syndrome. J Vasc Surg. 2011;54:819\u201331.","journal-title":"J Vasc Surg"},{"key":"9547_CR6","doi-asserted-by":"crossref","unstructured":"Radu F, Potcovaru CG, Salmen T, Filip PV, Pop C, Fierbinteanu-Braticievici C. The link between NAFLD and metabolic syndrome. Diagnostics 2023;13:614.","DOI":"10.3390\/diagnostics13040614"},{"key":"9547_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/dc12-0336","volume":"35","author":"K Esposito","year":"2012","unstructured":"Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35:2402\u201311.","journal-title":"Diabetes Care"},{"key":"9547_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/hep.24397","volume":"54","author":"TM Welzel","year":"2011","unstructured":"Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the united States: a study in the SEER-Medicare database. Hepatology. 2011;54:463\u201371.","journal-title":"Hepatology"},{"key":"9547_CR9","doi-asserted-by":"publisher","first-page":"124ra127","DOI":"10.1126\/scitranslmed.3003293","volume":"4","author":"C Lee","year":"2012","unstructured":"Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4:124ra127.","journal-title":"Sci Transl Med"},{"key":"9547_CR10","doi-asserted-by":"publisher","first-page":"103645","DOI":"10.1016\/j.jprot.2020.103645","volume":"217","author":"AL Mindikoglu","year":"2020","unstructured":"Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteom. 2020;217:103645.","journal-title":"J Proteom"},{"key":"9547_CR11","doi-asserted-by":"publisher","first-page":"18341","DOI":"10.1038\/s41598-020-73767-w","volume":"10","author":"AL Mindikoglu","year":"2020","unstructured":"Mindikoglu AL, Abdulsada MM, Jain A, Jalal PK, Devaraj S, Wilhelm ZR, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020;10:18341.","journal-title":"Sci Rep"},{"key":"9547_CR12","doi-asserted-by":"publisher","first-page":"100214","DOI":"10.1016\/j.metop.2022.100214","volume":"16","author":"AL Mindikoglu","year":"2022","unstructured":"Mindikoglu AL, Park J, Opekun AR, Abdulsada MM, Wilhelm ZR, Jalal PK, Devaraj S, Jung SY. Dawn-to-dusk dry fasting induces anti-atherosclerotic, anti-inflammatory, and anti-tumorigenic proteome in peripheral blood mononuclear cells in subjects with metabolic syndrome. Metabol Open. 2022;16:100214.","journal-title":"Metabol Open"},{"key":"9547_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.lfs.2004.02.014","volume":"75","author":"MW Wu","year":"2004","unstructured":"Wu MW, Li XM, Xian LJ, Levi F. Effects of meal timing on tumor progression in mice. Life Sci. 2004;75:1181\u201393.","journal-title":"Life Sci"},{"key":"9547_CR14","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"R de Cabo","year":"2019","unstructured":"de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381:2541\u201351.","journal-title":"N Engl J Med"},{"key":"9547_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O. The metabolism of carcinoma cells. J Cancer Res. 1925;9:148\u201363.","journal-title":"J Cancer Res"},{"key":"9547_CR16","doi-asserted-by":"publisher","first-page":"105965","DOI":"10.1016\/j.isci.2023.105965","volume":"26","author":"TE Shaiken","year":"2023","unstructured":"Shaiken TE, Grimm SL, Siam M, Williams A, Rezaeian AH, Kraushaar D, Ricco E, Robertson MJ, Coarfa C, Jain A, Malovannaya A, Stossi F, Opekun AR, Price AP, Dubrulle J. Transcriptome, proteome, and protein synthesis within the intracellular cytomatrix. iScience. 2023;26:105965.","journal-title":"iScience"},{"key":"9547_CR17","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1101\/gad.183500","volume":"14","author":"F Damiola","year":"2000","unstructured":"Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the Suprachiasmatic nucleus. Genes Dev. 2000;14:2950\u201361.","journal-title":"Genes Dev"},{"key":"9547_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0006-8993(86)90117-4","volume":"382","author":"JH Meijer","year":"1986","unstructured":"Meijer JH, Groos GA, Rusak B. Luminance coding in a circadian pacemaker: the Suprachiasmatic nucleus of the rat and the hamster. Brain Res. 1986;382:109\u201318.","journal-title":"Brain Res"},{"key":"9547_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.copbio.2020.08.009","volume":"70","author":"HL Boege","year":"2021","unstructured":"Boege HL, Bhatti MZ, St-Onge MP. Circadian rhythms and meal timing: impact on energy balance and body weight. Curr Opin Biotechnol. 2021;70:1\u20136.","journal-title":"Curr Opin Biotechnol"},{"key":"9547_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.physbeh.2014.12.044","volume":"140","author":"M Witbracht","year":"2015","unstructured":"Witbracht M, Keim NL, Forester S, Widaman A, Laugero K. Female breakfast skippers display a disrupted cortisol rhythm and elevated blood pressure. Physiol Behav. 2015;140:215\u201321.","journal-title":"Physiol Behav"},{"key":"9547_CR21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3945\/ajcn.116.151332","volume":"105","author":"A Nas","year":"2017","unstructured":"Nas A, Mirza N, Hagele F, Kahlhofer J, Keller J, Rising R, Kufer TA, Bosy-Westphal A. Impact of breakfast skipping compared with dinner skipping on regulation of energy balance and metabolic risk. Am J Clin Nutr. 2017;105:1351\u201361.","journal-title":"Am J Clin Nutr"},{"key":"9547_CR22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3945\/ajcn.2010.30101","volume":"92","author":"KJ Smith","year":"2010","unstructured":"Smith KJ, Gall SL, McNaughton SA, Blizzard L, Dwyer T, Venn AJ. Skipping breakfast: longitudinal associations with cardiometabolic risk factors in the childhood determinants of adult health study. Am J Clin Nutr. 2010;92:1316\u201325.","journal-title":"Am J Clin Nutr"},{"key":"9547_CR23","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/S0024-3205(03)00628-3","volume":"73","author":"LQ Qin","year":"2003","unstructured":"Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci. 2003;73:2467\u201375.","journal-title":"Life Sci"},{"key":"9547_CR24","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1210\/clinem\/dgaa354","volume":"105","author":"C Gu","year":"2020","unstructured":"Gu C, Brereton N, Schweitzer A, Cotter M, Duan D, Borsheim E, Wolfe RR, Pham LV, Polotsky VY, Jun JC. Metabolic effects of late dinner in healthy Volunteers-A randomized crossover clinical trial. J Clin Endocrinol Metab. 2020;105:2789\u2013802.","journal-title":"J Clin Endocrinol Metab"},{"key":"9547_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/jamainternmed.2020.4153","volume":"180","author":"DA Lowe","year":"2020","unstructured":"Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ. Effects of Time-Restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern Med. 2020;180:1491\u20139.","journal-title":"JAMA Intern Med"},{"key":"9547_CR26","unstructured":"Dunning A. The Phoenix Protocol Dry Fasting for Rapid Healing and Radical Life Extension: Functional Immortality. Independently Published, 2020."},{"key":"9547_CR27","unstructured":"Filonov SI. 20 Questions & Answers About Dry Fasting: A Complete Guide to Dry Fasting. Siberika Publishing, 2019."},{"key":"9547_CR28","first-page":"2131","volume":"81","author":"G Geelen","year":"1996","unstructured":"Geelen G, Greenleaf JE, Keil LC. Drinking-induced plasma vasopressin and norepinephrine changes in dehydrated humans. J Clin Endocrinol Metab. 1996;81:2131\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"9547_CR29","first-page":"H604","volume":"260","author":"AJ Palazzo","year":"1991","unstructured":"Palazzo AJ, Malik KU, Weis MT. Vasopressin stimulates the mobilization and metabolism of triacylglycerol in perfused rabbit hearts. Am J Physiol. 1991;260:H604\u2013612.","journal-title":"Am J Physiol"},{"key":"9547_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0022-4731(84)90202-4","volume":"20","author":"F Labrie","year":"1984","unstructured":"Labrie F, Giguere V, Proulx L, Lefevre G. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion. J Steroid Biochem. 1984;20:153\u201360.","journal-title":"J Steroid Biochem"},{"key":"9547_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000180283","volume":"23","author":"LJ Valenta","year":"1986","unstructured":"Valenta LJ, Elias AN, Eisenberg H. ACTH stimulation of adrenal epinephrine and norepinephrine release. Horm Res. 1986;23:16\u201320.","journal-title":"Horm Res"},{"key":"9547_CR32","doi-asserted-by":"publisher","first-page":"E1483","DOI":"10.1152\/ajpendo.00267.2013","volume":"305","author":"FA Graca","year":"2013","unstructured":"Graca FA, Goncalves DA, Silveira WA, Lira EC, Chaves VE, Zanon NM, Garofalo MA, Kettelhut IC, Navegantes LC. Epinephrine depletion exacerbates the fasting-induced protein breakdown in fast-twitch skeletal muscles. Am J Physiol Endocrinol Metab. 2013;305:E1483\u20131494.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9547_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0026-0495(99)90104-X","volume":"48","author":"SB Pedersen","year":"1999","unstructured":"Pedersen SB, Bak JF, Holck P, Schmitz O, Richelsen B. Epinephrine stimulates human muscle lipoprotein lipase activity in vivo. Metabolism. 1999;48:461\u20134.","journal-title":"Metabolism"},{"key":"9547_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1139\/apnm-2023-0462","volume":"49","author":"KAW Hillier","year":"2024","unstructured":"Hillier KAW, Longworth ZL, Vatanparast H. Healthcare professionals knowledge, attitude, practices, and perspectives providing care to Muslims in Western countries who fast during ramadan: a scoping review. Appl Physiol Nutr Metab. 2024;49:415\u201327.","journal-title":"Appl Physiol Nutr Metab"},{"key":"9547_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000013316","volume":"18","author":"AH Abdalla","year":"1998","unstructured":"Abdalla AH, Shaheen FA, Rassoul Z, Owda AK, Popovich WF, Mousa DH, al-Hawas F, al-Sulaiman MH, al-Khader AA. Effect of ramadan fasting on moslem kidney transplant recipients. Am J Nephrol. 1998;18:101\u20134.","journal-title":"Am J Nephrol"},{"key":"9547_CR36","doi-asserted-by":"publisher","first-page":"100274","DOI":"10.1016\/j.metop.2024.100274","volume":"21","author":"Z Al Lami","year":"2024","unstructured":"Al Lami Z, Kurtca M, Atique MU, Opekun AR, Siam MS, Jalal PK, Najafi B, Devaraj S, Mindikoglu AL. Dawn-to-dusk dry fasting decreases Circulating inflammatory cytokines in subjects with increased body mass index. Metabol Open. 2024;21:100274.","journal-title":"Metabol Open"},{"key":"9547_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/BJN19900119","volume":"63","author":"SH Cheah","year":"1990","unstructured":"Cheah SH, Ch\u2019ng SL, Husain R, Duncan MT. Effects of fasting during ramadan on urinary excretion in Malaysian Muslims. Br J Nutr. 1990;63:329\u201337.","journal-title":"Br J Nutr"},{"key":"9547_CR38","doi-asserted-by":"publisher","first-page":"662310","DOI":"10.3389\/fnut.2021.662310","volume":"8","author":"DA Koppold-Liebscher","year":"2021","unstructured":"Koppold-Liebscher DA, Klatte C, Demmrich S, Schwarz J, Kandil FI, Steckhan N, Ring R, Kessler CS, Jeitler M, Koller B, Ananthasubramaniam B, Eisenmann C, Mahler A, Boschmann M, Kramer A, Michalsen A. Effects of daytime dry fasting on hydration, glucose metabolism and circadian phase: A prospective exploratory cohort study in Baha\u2019i volunteers. Front Nutr. 2021;8:662310.","journal-title":"Front Nutr"},{"issue":"Suppl 2","key":"9547_CR39","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1038\/sj.ejcn.1601899","volume":"57","author":"JB Leiper","year":"2003","unstructured":"Leiper JB, Molla AM, Molla AM. Effects on health of fluid restriction during fasting in ramadan. Eur J Clin Nutr. 2003;57(Suppl 2):S30\u201338.","journal-title":"Eur J Clin Nutr"},{"key":"9547_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/150021a0","volume":"150","author":"K Mellanby","year":"1942","unstructured":"Mellanby K. Metabolic water and desiccation. Nature. 1942;150:21\u201321.","journal-title":"Nature"},{"key":"9547_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-642-81105-0_8","volume-title":"Water balance in land arthropods","author":"EB Edney","year":"1977","unstructured":"Edney EB. Metabolic water. In: Edney EB, editor. Water balance in land arthropods. Berlin, Heidelberg: Springer Berlin Heidelberg; 1977. pp. 189\u201395."},{"key":"9547_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/B978-0-12-383864-3.00003-X","volume-title":"Human biochemistry","author":"G Litwack","year":"2018","unstructured":"Litwack G: Chapter 3 - Introductory Discussion on Water, pH, Buffers, and General Features of Receptors, Channels, and Pumps. In: Litwack G, ed. Human Biochemistry (Second Edition). Boston: Academic Press, 2022; 45-70."},{"key":"9547_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0899-9007(01)00542-1","volume":"17","author":"MA Crook","year":"2001","unstructured":"Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17:632\u20137.","journal-title":"Nutrition"},{"key":"9547_CR44","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/282615a0","volume":"282","author":"DP Aden","year":"1979","unstructured":"Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979;282:615\u20136.","journal-title":"Nature"},{"key":"9547_CR45","unstructured":"HEPG2. Available at https:\/\/www.atcc.org\/products\/hb-8065. Accessed on September 10, 2023."},{"key":"9547_CR46","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada D, Cheung SW, Finegold MJ, Knowles BB. Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 2009;40:1512\u20135.","journal-title":"Hum Pathol"},{"key":"9547_CR47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/ac026117i","volume":"75","author":"J Rappsilber","year":"2003","unstructured":"Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal Chem. 2003;75:663\u201370.","journal-title":"Anal Chem"},{"key":"9547_CR48","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1074\/mcp.TIR118.000850","volume":"17","author":"AB Saltzman","year":"2018","unstructured":"Saltzman AB, Leng M, Bhatt B, Singh P, Chan DW, Dobrolecki L, Chandrasekaran H, Choi JM, Jain A, Jung SY, Lewis MT, Ellis MJ, Malovannaya A. GpGrouper: A peptide grouping algorithm for Gene-Centric inference and quantitation of Bottom-Up proteomics data. Mol Cell Proteom. 2018;17:2270\u201383.","journal-title":"Mol Cell Proteom"},{"key":"9547_CR49","unstructured":"SAS software. http:\/\/www.SAS.com\/. The data analysis for this paper was generated using SAS software, Version 9.4 of the SAS system for Windows. Copyright \u00a9 2020 SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc, Cary, NC, USA."},{"key":"9547_CR50","doi-asserted-by":"publisher","first-page":"lqz019","DOI":"10.1093\/nargab\/lqz019","volume":"2","author":"M Akhmedov","year":"2020","unstructured":"Akhmedov M, Martinelli A, Geiger R, Kwee I. Omics playground: a comprehensive self-service platform for visualization, analytics and exploration of big omics data. NAR Genom Bioinform. 2019;2:lqz019.","journal-title":"NAR Genom Bioinform"},{"key":"9547_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/cmb.2012.0092","volume":"20","author":"N Tuncbag","year":"2013","unstructured":"Tuncbag N, Braunstein A, Pagnani A, Huang SS, Chayes J, Borgs C, Zecchina R, Fraenkel E. Simultaneous reconstruction of multiple signaling pathways via the prize-collecting steiner forest problem. J Comput Biol. 2013;20:124\u201336.","journal-title":"J Comput Biol"},{"key":"9547_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijc.33982","volume":"151","author":"ST Orange","year":"2022","unstructured":"Orange ST, Jordan AR, Odell A, Kavanagh O, Hicks KM, Eaglen T, Todryk S, Saxton JM. Acute aerobic exercise-conditioned serum reduces colon cancer cell proliferation in vitro through interleukin-6-induced regulation of DNA damage. Int J Cancer. 2022;151:265\u201374.","journal-title":"Int J Cancer"},{"key":"9547_CR53","first-page":"24","volume":"27","author":"CM Soares","year":"2021","unstructured":"Soares CM, Teixeira AM, Sarmento H, Silva FM, Rusenhack MC, Furmann M, Nobre PR, Fachada MA, Urbano AM, Ferreira JP. Effect of exercise-conditioned human serum on the viability of cancer cell cultures: A systematic review and meta-analysis. Exerc Immunol Rev. 2021;27:24\u201341.","journal-title":"Exerc Immunol Rev"},{"issue":"Suppl 20","key":"9547_CR54","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/1841570b0","volume":"184","author":"K Penttinen","year":"1959","unstructured":"Penttinen K, Saxen E. Growth-controlling action of human serum in cell culture. Nature. 1959;184(Suppl 20):1570\u20131.","journal-title":"Nature"},{"key":"9547_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3181\/00379727-70-16884","volume":"70","author":"ER Norris","year":"1949","unstructured":"Norris ER, Majnarich JJ. Cell proliferation accelerating and inhibiting substances in normal and cancer blood and urine. Proc Soc Exp Biol Med. 1949;70:229\u201334.","journal-title":"Proc Soc Exp Biol Med"},{"key":"9547_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1152\/ajplegacy.1948.153.3.483","volume":"153","author":"ER Norris","year":"1948","unstructured":"Norris ER, Majnarich JJ. Effect of normal blood serum and blood serum from neoplastic disease on cell proliferation in bone marrow cultures. Am J Physiol. 1948;153:483\u20137.","journal-title":"Am J Physiol"},{"key":"9547_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/jnci\/35.1.67","volume":"35","author":"E Saxen","year":"1965","unstructured":"Saxen E, Penttinen K. Differences in the effect of individual human Sera on cell cultures. J Natl Cancer Inst. 1965;35:67\u201373.","journal-title":"J Natl Cancer Inst"},{"key":"9547_CR58","doi-asserted-by":"publisher","first-page":"741","DOI":"10.15252\/emmm.201607222","volume":"9","author":"C Mogler","year":"2017","unstructured":"Mogler C, K\u00f6nig C, Wieland M, Runge A, Besemfelder E, Komljenovic D, Longerich T, Schirmacher P, Augustin HG. Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin. EMBO Mol Med. 2017;9:741\u20139.","journal-title":"EMBO Mol Med"},{"key":"9547_CR59","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1073\/pnas.0511306103","volume":"103","author":"A Nanda","year":"2006","unstructured":"Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, Vogelstein B, St Croix B, Kinzler KW, Huso DL. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A. 2006;103:3351\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9547_CR60","doi-asserted-by":"publisher","first-page":"e107146","DOI":"10.1371\/journal.pone.0107146","volume":"9","author":"AJ Naylor","year":"2014","unstructured":"Naylor AJ, McGettrick HM, Maynard WD, May P, Barone F, Croft AP, Egginton S, Buckley CD. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis. PLoS ONE. 2014;9:e107146.","journal-title":"PLoS ONE"},{"key":"9547_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cm.20245","volume":"65","author":"N Vlahovich","year":"2008","unstructured":"Vlahovich N, Schevzov G, Nair-Shaliker V, Ilkovski B, Artap ST, Joya JE, Kee AJ, North KN, Gunning PW, Hardeman EC. Tropomyosin 4 defines novel filaments in skeletal muscle associated with muscle remodelling\/regeneration in normal and diseased muscle. Cell Motil Cytoskeleton. 2008;65:73\u201385.","journal-title":"Cell Motil Cytoskeleton"},{"key":"9547_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12885-015-1757-0","volume":"15","author":"V Boccardi","year":"2015","unstructured":"Boccardi V, Marano L, Rossetti RR, Rizzo MR, di Martino N, Paolisso G. Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker. BMC Cancer. 2015;15:703.","journal-title":"BMC Cancer"},{"key":"9547_CR63","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1054\/bjoc.2000.1410","volume":"83","author":"OJ Cordero","year":"2000","unstructured":"Cordero OJ, Ayude D, Nogueira M, Rodriguez-Berrocal FJ, de la Cadena MP. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer. 2000;83:1139\u201346.","journal-title":"Br J Cancer"},{"key":"9547_CR64","first-page":"8079","volume":"61","author":"C Mouta Carreira","year":"2001","unstructured":"Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 2001;61:8079\u201384.","journal-title":"Cancer Res"},{"key":"9547_CR65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/jca.8486","volume":"5","author":"K Nunomiya","year":"2014","unstructured":"Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Kimura T, Aida Y, Nemoto T, Sato M, Kishi H, Nakano H, Sato K, Kubota I. Relationship between serum level of lymphatic vessel endothelial hyaluronan Receptor-1 and prognosis in patients with lung Cancer. J Cancer. 2014;5:242\u20137.","journal-title":"J Cancer"},{"key":"9547_CR66","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3892\/mco.2013.167","volume":"1","author":"K Kitagawa","year":"2013","unstructured":"Kitagawa K, Nakajima G, Kuramochi H, Ariizumi SI, Yamamoto M. Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma. Mol Clin Oncol. 2013;1:1039\u201348.","journal-title":"Mol Clin Oncol"},{"key":"9547_CR67","first-page":"509","volume":"6","author":"JH Li","year":"2016","unstructured":"Li JH, Wang YC, Qin CD, Yao RR, Zhang R, Wang Y, Xie XY, Zhang L, Wang YH, Ren ZG. Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation. Am J Cancer Res. 2016;6:509\u201321.","journal-title":"Am J Cancer Res"},{"key":"9547_CR68","doi-asserted-by":"publisher","first-page":"e32775","DOI":"10.1371\/journal.pone.0032775","volume":"7","author":"XY Huang","year":"2012","unstructured":"Huang XY, Shi GM, Devbhandari RP, Ke AW, Wang Y, Wang XY, Wang Z, Shi YH, Xiao YS, Ding ZB, Dai Z, Xu Y, Jia WP, Tang ZY, Fan J, Zhou J. Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection. PLoS ONE. 2012;7:e32775.","journal-title":"PLoS ONE"},{"key":"9547_CR69","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000505201","volume":"27","author":"IE Papagiannopoulos-Vatopaidinos","year":"2020","unstructured":"Papagiannopoulos-Vatopaidinos IE, Papagiannopoulou M, Sideris V. Dry fasting physiology: responses to hypovolemia and hypertonicity. Complement Med Res. 2020;27:242\u201351.","journal-title":"Complement Med Res"},{"key":"9547_CR70","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.diabres.2019.05.023","volume":"153","author":"MAE Faris","year":"2019","unstructured":"Faris MAE, Madkour MI, Obaideen AK, Dalah EZ, Hasan HA, Radwan H, Jahrami HA, Hamdy O, Mohammad MG. Effect of ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals. Diabetes Res Clin Pract. 2019;153:166\u201375.","journal-title":"Diabetes Res Clin Pract"},{"key":"9547_CR71","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.nutres.2012.06.021","volume":"32","author":"MA Faris","year":"2012","unstructured":"Faris MA, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK, Salem ML. Intermittent fasting during ramadan attenuates Proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32:947\u201355.","journal-title":"Nutr Res"},{"key":"9547_CR72","doi-asserted-by":"publisher","first-page":"113090","DOI":"10.1016\/j.physbeh.2020.113090","volume":"225","author":"H Zouhal","year":"2020","unstructured":"Zouhal H, Bagheri R, Ashtary-Larky D, Wong A, Triki R, Hackney AC, Laher I, Abderrahman AB. Effects of ramadan intermittent fasting on inflammatory and biochemical biomarkers in males with obesity. Physiol Behav. 2020;225:113090.","journal-title":"Physiol Behav"},{"key":"9547_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ol.2023.14192","volume":"27","author":"J Gao","year":"2024","unstructured":"Gao J, Huo Z, Song X, Shao Q, Ren W, Huang X, Zhou S, Tang X. EGFR mediates epithelial\u2013mesenchymal transition through the Akt\/GSK-3\u03b2\/Snail signaling pathway to promote liver cancer proliferation and migration. Oncol Lett. 2024;27:59.","journal-title":"Oncol Lett"},{"key":"9547_CR74","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","volume":"82","author":"B Hu","year":"2022","unstructured":"Hu B, Zou T, Qin W, Shen X, Su Y, Li J, Chen Y, Zhang Z, Sun H, Zheng Y, Wang CQ, Wang Z, Li TE, Wang S, Zhu L, Wang X, Fu Y, Ren X, Dong Q, Qin LX. Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma. Cancer Res. 2022;82:3845\u201357.","journal-title":"Cancer Res"},{"key":"9547_CR75","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3892\/ol.2024.14428","volume":"28","author":"C Wang","year":"2024","unstructured":"Wang C, Chen S, Zhang R, Chen M, Yang X, He Y, Shangguan Z, Mao Q, Zhang Z, Ying S. Apolipoprotein A-1 downregulation promotes basal-like breast cancer cell proliferation and migration associated with DNA methylation. Oncol Lett. 2024;28:295.","journal-title":"Oncol Lett"},{"key":"9547_CR76","doi-asserted-by":"publisher","first-page":"70654","DOI":"10.18632\/oncotarget.12203","volume":"7","author":"XL Ma","year":"2016","unstructured":"Ma XL, Gao XH, Gong ZJ, Wu J, Tian L, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. 2016;7:70654\u201368.","journal-title":"Oncotarget"},{"key":"9547_CR77","doi-asserted-by":"publisher","first-page":"pbad021","DOI":"10.1093\/pcmedi\/pbad021","volume":"6","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen S, Xiao X, Yang F, Wang J, Zong H, Gao Y, Huang C, Xu X, Fang M, Zhang X, Gao C. Impact of Apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma. Precis Clin Med. 2023;6:pbad021.","journal-title":"Precis Clin Med"},{"key":"9547_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yexcr.2018.02.017","volume":"365","author":"JI Heger","year":"2018","unstructured":"Heger JI, Froehlich K, Pastuschek J, Schmidt A, Baer C, Mrowka R, Backsch C, Schleussner E, Markert UR, Schmidt A. Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum. Exp Cell Res. 2018;365:57\u201365.","journal-title":"Exp Cell Res"},{"key":"9547_CR79","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.1038\/s41598-018-29763-2","volume":"8","author":"R Steenbergen","year":"2018","unstructured":"Steenbergen R, Oti M, Ter Horst R, Tat W, Neufeldt C, Belovodskiy A, Chua TT, Cho WJ, Joyce M, Dutilh BE, Tyrrell DL. Establishing normal metabolism and differentiation in hepatocellular carcinoma cells by culturing in adult human serum. Sci Rep. 2018;8:11685.","journal-title":"Sci Rep"},{"key":"9547_CR80","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149\u201360.","journal-title":"Behav Res Methods"},{"key":"9547_CR81","doi-asserted-by":"publisher","first-page":"100162","DOI":"10.1016\/j.metop.2021.100162","volume":"13","author":"SI Bhatti","year":"2022","unstructured":"Bhatti SI, Mindikoglu AL. The impact of dawn to sunset fasting on immune system and its clinical significance in COVID-19 pandemic. Metabol Open. 2022;13:100162.","journal-title":"Metabol Open"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-025-09547-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T03:43:38Z","timestamp":1750736618000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-025-09547-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9547"],"URL":"https:\/\/doi.org\/10.1186\/s12014-025-09547-3","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}